Promoter polymorphisms in the ATP binding cassette transporter gene influence production of cell-derived microparticles and are highly associated with susceptibility to severe malaria in humans

Infection and Immunity

Volumn 81, Issue 4, 2013, Pages 1287-1294

  Sahu, Upasana ^a   Mohapatra, Biranchi N ^b   Kar, Shantanu K ^a   Ranjit, Manoranjan ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE ICMR   (India)

^b SCB MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1;

ADOLESCENT; ADULT; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MEMBRANE MICROPARTICLE; MEMBRANE TRANSPORT; MULTIPLE ORGAN FAILURE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; WILD TYPE;

ADOLESCENT; ADULT; ATP-BINDING CASSETTE TRANSPORTERS; CELL-DERIVED MICROPARTICLES; FEMALE; FLOW CYTOMETRY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 84875540653     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01175-12     Document Type: Article

References (31)

1. Turner GD, Morrison H, Jones M. 1994. An immunohistochemical study of the pathology of fatal malaria: evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am. J. Pathol. 145:1057-1069.
2. Moxon CA, Heyderman RS, Wassmer SC. 2009. Dysregulation of coagulation in cerebral malaria. Mol. Biochem. Parasitol. 166:99-108.
3. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214-217.
4. Seydel KB, Milner DA, Jr, Kamiza SB, Molyneux ME, Taylor TE. 2006. The distribution and intensity of parasite sequestration in comatose Malawian children. J. Infect. Dis. 194:208-215.
5. Idro R, Jenkins NE, Newton CR. 2005. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 4:827-840.
6. Combes V, Coltel N, Alibert M, van Eck M, Raymond C, Juhan-Vague I, Grau GE, Chimini G. 2005. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am. J. Pathol. 166:295-302.
7. Combes V, Coltel N, Faille D, Wassmer SC, Grau GE. 2006. Cerebral malaria: role of microparticles and platelets in alterations of the bloodbrain barrier. Int. J. Parasitol. 36:541-546.
8. Shet AS. 2008. Characterizing blood microparticles: technical aspects and challenges. Vascular Health Risk Manag. 4:769-774.
9. Freyssinet JM. 2003. Cellular microparticles: what are they bad or good for? J. Thromb. Haemost. 1:1655-1662.
10. Berckmans RJ, Nieuwland R, Böing AN, Hack CE, Struk A. 2001. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost. 85:639-646.
11. Ando M, Iwata A, Ozeki Y, Tsuchiya K, Akiba T, Nihei H. 2002. Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. Kidney Int. 62:1757-1763.
12. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, ten Have K, Eijsman L, Hack CE, Sturk A. 1997. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 96:3534-3541.
13. Combes V, Taylor TE, Juhan-Vague I, Mege JL, Mwenechanya J, Tembo M, Grau GE, Molyneux ME. 2004. Circulating endothelial microparticles in Malawian children with severe falciparum malaria complicated with coma. JAMA 291:2542-2544.
14. Fujimi S, Ogura H, Tanaka H, Koh T, Hosotsubo H, Nakamori Y, Kuwagata Y, Shimazu T, Sugimoto H. 2002. Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. J. Trauma 52:443-448.
15. Pankoui Mfonkeu JB, Gouado I, Fotso Kuaté H, Zambou O, Zollo PHA, Grau GER, Combes V. 2010. Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One 5:e13415. doi:10.1371/journal.pone.0013415.
16. van Meer G, Halter D, Sprong H, Somerharju P, Egmond MR. 2006. ABC lipid transporters: extruders, flippases, or flopless activators? FEBS Lett. 580:1171-1177.
17. Drobnik W, Borsukova H, Bottcher A, Pfeiffer A, Liebisch G, Schutz GJ, Schindler H, Schmitz G. 2002. Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterolbased microdomains. Traffic 3:268-278.
18. Nandi S, Ma L, Denis M, Karwatsky J, Li Z, Jiang XC, Zha X. 2009. ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity. J. Lipid Res. 50:456-466.
19. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, Assmann G. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22:352-355.
20. Oram JF, Vaughan AM. 2006. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ. Res. 99:1031-1043.
21. Lutucuta S, Ballantyne CM, Elghannam H, Gotto AM, Jr, Marian AJ. 2001. Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ. Res. 88:969-973.
22. Ranjit MR. 2006. The epidemiology of malaria in Orissa. ICMR Bull. 36:29-38.
23. Metzger WG, Mordmuller BG, Kremsner PG. 1995. Malaria pigment in leucocytes. Trans. R. Soc. Trop. Med. Hyg. 89:637-638.
24. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. 1993. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol. Biochem. Parasitol. 58:283-292.
25. World Health Organization. 2000. Communicable diseases cluster: severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl 1):S1-S90.
26. Dacie L. 1991. G6PD assay, p 205-214. In Practical haematology, 7th ed. Churchill Livingstone, Singapore, Philippines.
27. Katz N, Coelho PMZ, Pellegrino J. 1970. Evaluation of Kato's method through the recovery of Schistosoma mansoni eggs added to human feces. J. Parasitol. 56:5.
28. Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, Chimini G. 2000. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2:399-406.
29. Shet AS, Key NS, Hebbel RP. 2004. Measuring circulating cell-derived microparticles. J. Thromb. Haemost. 2:1848-1850.
30. Pasdar A, Yadegarfar G, Cumming A, Whalley L, St Clair D, MacLeod MJ. 2007. Effect of ABCA1 gene polymorphisms on ischaemic stroke risk and relationship with lipid profile. BMC Med. Genet. 8:30. doi:c17 10 .1186/1471-2350-8-30.
31. Takagi S, Iwai N, Miyazaki S, Nonogi H, Goto Y. 2002. Relationship between ABCA1 genetic variation and HDL cholesterol level in subjects with ischemic heart diseases in Japanese. Thromb. Haemost. 88:369-370. Sahu et al. 1294